The global live cell imaging market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global live cell imaging market is expected to grow at a CAGR ~9.0 % during the forecast period of 2018–2023.
Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. The increasing prevalence of chronic diseases and growing government funding in cell-based research are propelling the growth of this market. For instance, funding institutes such as Health Connexions, National Institute of Health, and W.M. Keck Foundation have granted funds to institutes such as Harvard School of Medicine, Perdue University, and Weldon School of Biomedical Engineering for the development of imaging technologies to be applied in the field of health, food, and environment. Furthermore, adoption of high content screening techniques in drug discovery and cell biology boosts the growth of the global live cell imaging market.
However, the lack of availability of skilled professional and the high cost of high-content screening systems may hinder the growth of the market during the forecast period.
Key Players
Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), and BioTek Instruments (U.S.) are some prominent players in this market.
Segmentation
The global live cell imaging market is segmented on the basis of the product, technology, application, and end-user.
On the basis of product, the market is classified as equipment, consumables, and software. The equipment is further segmented as microscopes, standalone systems, cell analyzer, and image-capturing devices. The microscopes are further sub-segmented as conventional microscopes, confocal microscopes, and advanced fluorescence microscopes. The consumables are sub-segmented as assay kits, reagents, media, and others.
The global live cell imaging market on the basis of technology is segmented as fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high-content analysis, ratiometric imaging, fluorescence in situ hybridization, total internal reflection fluorescence microscopy, multiphoton excitation microscopy and other technologies.
On the basis of application, the market is segmented into cell biology, stem cells, developmental biology, and drug discovery.
On the basis of end-user, the market is segmented as pharmaceutical companies, biotechnology companies, hospitals, diagnostic laboratories, and others.
Global Live Cell Imaging Market, by Product
- Equipment
- Microscopes
- Conventional Microscopes
- Confocal Microscopes
- Advanced Fluorescence Microscopes
- Standalone Systems
- Cell Analyzers
- Image-capturing Devices
- Consumables
- Assay Kits
- Reagents
- Media
- Others
- Software
Global Live Cell Imaging Market, by Technology
- Fluorescence Recovery After Photobleaching (FRAP)
- Fluorescence Resonance Energy Transfer (FRET)
- High-content Analysis
- Ratiometric Imaging
- Fluorescence In Situ Hybridization (FISH)
- Total Internal Reflection Fluorescence Microscopy (TRIF)
- Multiphoton Excitation Microscopy (MPE)
- Others
Global Live Cell Imaging Market, by Application
- Cell Biology
- Stem Cells
- Developmental Biology
- Drug Discovery
Global Live Cell Imaging Market, by End-user
- Pharmaceutical Companies
- Biotechnological Companies
- Hospitals
- Diagnostic Laboratories
- Others
Request Customization
Get a Sample
Get a Sample
Request Customization